1	Hedgehog	Hedgehog	B-NP	NN	O	2	NMOD	-1
2	signaling	signaling	I-NP	NN	O	0	ROOT	0
3	in	in	B-PP	IN	O	2	NMOD	-1
4	the	the	B-NP	DT	O	7	NMOD	-1
5	murine	murine	I-NP	JJ	O	7	NMOD	-1
6	melanoma	melanoma	I-NP	NN	O	7	NMOD	-1
7	microenvironment	microenvironment	I-NP	NN	O	3	PMOD	-1
8	.	.	O	.	O	2	P	-1

1	The	The	B-NP	DT	O	5	NMOD	-1
2	Hedgehog	Hedgehog	I-NP	NNP	O	5	NMOD	-1
3	intercellular	intercellular	I-NP	JJ	O	5	NMOD	-1
4	signaling	signaling	I-NP	NN	O	5	NMOD	0
5	pathway	pathway	I-NP	NN	O	6	SUB	0
6	regulates	regulate	B-VP	VBZ	O	0	ROOT	0
7	cell	cell	B-NP	NN	O	6	OBJ	-1
8	proliferation	proliferation	I-NP	NN	O	7	NMOD	1	proliferation
9	and	and	O	CC	O	7	NMOD	-1
10	differentiation	differentiation	B-NP	NN	O	7	NMOD	2	differentiation
11	.	.	O	.	O	6	P	-1

1	This	This	B-NP	DT	O	2	NMOD	-1
2	pathway	pathway	I-NP	NN	O	3	SUB	0
3	has	have	B-VP	VBZ	O	0	ROOT	-1
4	been	be	I-VP	VBN	O	3	VC	-1
5	implicated	implicate	I-VP	VBN	O	4	VC	0
6	to	to	I-VP	TO	O	7	VMOD	-1
7	play	play	I-VP	VB	O	5	VMOD	0
8	a	a	B-NP	DT	O	9	NMOD	-1
9	role	role	I-NP	NN	O	7	OBJ	0
10	in	in	B-PP	IN	O	7	VMOD	-1
11	the	the	B-NP	DT	O	12	NMOD	-1
12	pathogenesis	pathogenesis	I-NP	NN	O	10	PMOD	0
13	of	of	B-PP	IN	O	12	NMOD	-1
14	cancer	cancer	B-NP	NN	O	13	PMOD	-1
15	and	and	B-PP	CC	O	10	PMOD	-1
16	in	in	B-PP	IN	O	10	PMOD	-1
17	embryonic	embryonic	B-NP	JJ	O	20	NMOD	-1
18	blood	blood	I-NP	NN	O	20	NMOD	-1
19	vessel	vessel	I-NP	NN	O	20	NMOD	-1
20	development	development	I-NP	NN	O	16	PMOD	2	development
21	.	.	O	.	O	3	P	-1

1	In	In	B-PP	IN	O	14	VMOD	-1
2	the	the	B-NP	DT	O	4	NMOD	-1
3	current	current	I-NP	JJ	O	4	NMOD	-1
4	study	study	I-NP	NN	O	1	PMOD	-1
5	,	,	O	,	O	14	P	-1
6	Hedgehog	Hedgehog	B-NP	NN	O	7	NMOD	-1
7	signaling	signaling	I-NP	NN	O	14	SUB	0
8	in	in	B-PP	IN	O	7	NMOD	-1
9	tumor	tumor	B-NP	NN	O	11	NMOD	-1
10	related	related	I-NP	JJ	O	9	AMOD	-1
11	vasculature	vasculature	I-NP	NN	O	13	NMOD	-1
12	and	and	I-NP	CC	O	13	NMOD	-1
13	microenvironment	microenvironment	I-NP	NN	O	8	PMOD	-1
14	was	be	B-VP	VBD	O	0	ROOT	-1
15	examined	examine	I-VP	VBN	O	14	VC	-1
16	using	use	B-VP	VBG	O	15	VMOD	-1
17	human	human	B-NP	JJ	B-cell_type	21	NMOD	-1
18	umbilical	umbilical	I-NP	JJ	I-cell_type	21	NMOD	-1
19	vein	vein	I-NP	NN	I-cell_type	21	NMOD	-1
20	endothelial	endothelial	I-NP	JJ	I-cell_type	21	NMOD	-1
21	cells	cell	I-NP	NNS	I-cell_type	23	NMOD	-1
22	and	and	O	CC	O	23	NMOD	-1
23	B16F0	B16F0	B-NP	NN	B-protein	29	NMOD	-1
24	(	(	O	(	O	27	DEP	-1
25	murine	murine	B-NP	JJ	O	26	NMOD	-1
26	melanoma	melanoma	I-NP	NN	O	27	DEP	-1
27	)	)	O	)	O	23	NMOD	-1
28	tumors	tumor	B-NP	NNS	O	29	NMOD	-1
29	models	model	I-NP	NNS	O	16	OBJ	-1
30	.	.	O	.	O	14	P	-1

1	Use	Use	B-NP	NN	O	11	SUB	0
2	of	of	B-PP	IN	O	1	NMOD	-1
3	exogenous	exogenous	B-NP	JJ	O	5	NMOD	-1
4	Sonic	Sonic	I-NP	JJ	O	5	NMOD	-1
5	hedgehog	hedgehog	I-NP	NN	O	9	NMOD	-1
6	(	(	O	(	O	9	NMOD	-1
7	Shh	Shh	B-NP	NN	O	9	NMOD	-1
8	)	)	O	)	O	9	NMOD	-1
9	peptide	peptide	B-NP	NN	O	2	PMOD	-1
10	significantly	significantly	B-ADVP	RB	O	11	VMOD	-1
11	increased	increase	B-VP	VBD	O	0	ROOT	17	increased
12	BrdU	BrdU	B-NP	NN	B-protein	13	NMOD	-1
13	incorporation	incorporation	I-NP	NN	O	11	OBJ	14	incorporation
14	in	in	B-PP	IN	O	13	NMOD	-1
15	endothelial	endothelial	B-NP	JJ	B-cell_type	16	NMOD	-1
16	cells	cell	I-NP	NNS	I-cell_type	14	PMOD	-1
17	in	in	B-PP	FW	O	13	NMOD	-1
18	vitro	vitro	B-NP	FW	O	17	AMOD	-1
19	by	by	B-PP	IN	O	11	VMOD	-1
20	a	a	B-NP	DT	O	21	NMOD	-1
21	factor	factor	I-NP	NN	O	19	PMOD	-1
22	of	of	B-PP	IN	O	21	NMOD	-1
23	2	2	B-NP	CD	O	22	PMOD	-1
24	(	(	O	(	O	29	DEP	-1
25	P	P	B-NP	NN	O	29	DEP	-1
26	less	less	B-ADJP	JJR	O	25	NMOD	-1
27	than	than	B-PP	IN	O	26	AMOD	-1
28	0.001	0.001	B-NP	CD	O	27	PMOD	-1
29	)	)	O	)	O	23	NMOD	-1
30	.	.	O	.	O	11	P	-1

1	The	The	B-NP	DT	O	5	NMOD	-1
2	Hedgehog	Hedgehog	I-NP	NNP	O	5	NMOD	-1
3	pathway	pathway	I-NP	NN	O	5	NMOD	0
4	antagonist	antagonist	I-NP	NN	O	5	NMOD	-1
5	cyclopamine	cyclopamine	I-NP	NN	O	7	SUB	-1
6	effectively	effectively	B-ADVP	RB	O	7	VMOD	-1
7	reduced	reduce	B-VP	VBD	O	0	ROOT	18	reduced
8	Shh-induced	Shh-induced	B-NP	JJ	O	9	NMOD	17	induced
9	proliferation	proliferation	I-NP	NN	O	7	OBJ	1	proliferation
10	to	to	B-PP	TO	O	9	NMOD	-1
11	control	control	B-NP	NN	O	12	NMOD	0
12	levels	level	I-NP	NNS	O	10	PMOD	-1
13	.	.	O	.	O	7	P	-1

1	To	To	B-VP	TO	O	2	VMOD	-1
2	study	study	I-VP	VB	O	17	VMOD	-1
3	Hedgehog	Hedgehog	B-NP	NN	O	4	NMOD	-1
4	signaling	signaling	I-NP	NN	O	11	NMOD	0
5	in	in	B-ADVP	FW	O	4	NMOD	-1
6	vivo	vivo	I-ADVP	FW	O	5	AMOD	-1
7	a	a	B-NP	DT	O	11	NMOD	-1
8	hind	hind	I-NP	NN	O	11	NMOD	-1
9	limb	limb	I-NP	NN	O	11	NMOD	-1
10	tumor	tumor	I-NP	NN	O	11	NMOD	-1
11	model	model	I-NP	NN	O	17	SUB	-1
12	with	with	B-PP	IN	O	11	NMOD	-1
13	the	the	B-NP	DT	O	16	NMOD	-1
14	B16F0	B16F0	I-NP	NN	B-cell_line	16	NMOD	-1
15	cell	cell	I-NP	NN	I-cell_line	16	NMOD	-1
16	line	line	I-NP	NN	I-cell_line	12	PMOD	-1
17	was	be	B-VP	VBD	O	0	ROOT	-1
18	used	use	I-VP	VBN	O	17	VC	0
19	.	.	O	.	O	17	P	-1

1	Treatment	Treatment	B-NP	NN	O	7	SUB	19	Treatment
2	with	with	B-PP	IN	O	1	NMOD	-1
3	25	25	B-NP	CD	O	5	NMOD	-1
4	mg/kg	mg/kg	I-NP	NN	O	5	NMOD	-1
5	cyclopamine	cyclopamine	I-NP	NN	O	2	PMOD	-1
6	significantly	significantly	B-ADVP	RB	O	7	VMOD	-1
7	attenuated	attenuate	B-VP	VBD	O	36	VMOD	18	attenuated
8	BrdU	BrdU	B-NP	NN	B-protein	9	NMOD	-1
9	incorporation	incorporation	I-NP	NN	O	7	OBJ	14	incorporation
10	in	in	B-PP	IN	O	9	NMOD	-1
11	tumor	tumor	B-NP	NN	B-cell_type	12	NMOD	-1
12	cells	cell	I-NP	NNS	I-cell_type	10	PMOD	-1
13	threefold	threefold	B-ADVP	RB	O	7	VMOD	-1
14	(	(	O	(	O	19	DEP	-1
15	P	P	B-NP	NN	O	19	DEP	-1
16	less	less	B-ADJP	JJR	O	15	NMOD	-1
17	than	than	B-PP	IN	O	16	AMOD	-1
18	0.001	0.001	B-NP	CD	O	17	PMOD	-1
19	)	)	O	)	O	13	AMOD	-1
20	,	,	O	,	O	7	P	-1
21	in	in	B-PP	IN	O	7	VMOD	-1
22	tumor	tumor	B-NP	NN	B-cell_type	25	NMOD	-1
23	related	related	I-NP	JJ	I-cell_type	22	AMOD	-1
24	endothelial	endothelial	I-NP	JJ	I-cell_type	25	NMOD	-1
25	cells	cell	I-NP	NNS	I-cell_type	21	PMOD	-1
26	threefold	threefold	B-ADVP	RB	O	7	VMOD	-1
27	(	(	O	(	O	31	DEP	-1
28	P	P	B-NP	NN	O	31	DEP	-1
29	=	=	B-VP	SYM	O	28	NMOD	-1
30	0.004	0.004	B-NP	CD	O	29	AMOD	-1
31	)	)	O	)	O	26	AMOD	-1
32	,	,	O	,	O	36	P	-1
33	and	and	O	CC	O	36	NMOD	-1
34	delayed	delay	B-NP	VBN	O	36	NMOD	18	delayed
35	tumor	tumor	I-NP	NN	O	36	NMOD	-1
36	growth	growth	I-NP	NN	O	0	ROOT	4	growth
37	by	by	B-PP	IN	O	36	NMOD	-1
38	4	4	B-NP	CD	O	39	NMOD	-1
39	days	day	I-NP	NNS	O	37	PMOD	-1
40	.	.	O	.	O	36	P	-1

1	Immunohistochemistry	Immunohistochemistry	B-NP	NN	O	2	SUB	-1
2	revealed	reveal	B-VP	VBD	O	0	ROOT	-1
3	that	that	B-SBAR	IN	O	15	DEP	-1
4	the	the	B-NP	DT	O	6	NMOD	-1
5	Hedgehog	Hedgehog	I-NP	NN	B-protein	6	NMOD	-1
6	receptor	receptor	I-NP	NN	I-protein	7	NMOD	-1
7	Patched	Patched	B-NP	NNP	O	8	SUB	-1
8	was	be	B-VP	VBD	O	3	SBAR	-1
9	localized	localized	B-ADJP	JJ	O	8	PRD	14	localized
10	to	to	B-PP	TO	O	9	AMOD	-1
11	the	the	B-NP	DT	O	13	NMOD	-1
12	tumor	tumor	I-NP	NN	O	13	NMOD	-1
13	stroma	stroma	I-NP	NN	O	10	PMOD	-1
14	and	and	O	CC	O	15	DEP	-1
15	that	that	B-SBAR	IN	O	2	VMOD	-1
16	B16F0	B16F0	B-NP	NN	B-cell_line	17	NMOD	-1
17	cells	cell	I-NP	NNS	I-cell_line	18	SUB	-1
18	expressed	express	B-VP	VBD	O	15	SBAR	9	expressed
19	Shh	Shh	B-NP	NN	O	20	NMOD	-1
20	peptide	peptide	I-NP	NN	O	18	OBJ	-1
21	.	.	O	.	O	2	P	-1

1	Furthermore	Furthermore	B-ADVP	RB	O	6	VMOD	-1
2	,	,	O	,	O	6	P	-1
3	mouse	mouse	B-NP	NN	B-cell_type	5	NMOD	-1
4	embryonic	embryonic	I-NP	JJ	I-cell_type	5	NMOD	-1
5	fibroblasts	fibroblast	I-NP	NNS	I-cell_type	6	SUB	-1
6	required	require	B-VP	VBD	O	0	ROOT	0
7	the	the	B-NP	DT	O	8	NMOD	-1
8	presence	presence	I-NP	NN	O	6	OBJ	0
9	of	of	B-PP	IN	O	8	NMOD	-1
10	B16F0	B16F0	B-NP	NN	B-cell_line	11	NMOD	-1
11	cells	cell	I-NP	NNS	I-cell_line	9	PMOD	-1
12	to	to	B-VP	TO	O	13	VMOD	-1
13	express	express	I-VP	VB	O	8	NMOD	9	express
14	Patched	Patch	I-VP	VBN	O	13	VC	-1
15	in	in	B-PP	IN	O	14	VMOD	-1
16	a	a	B-NP	DT	O	19	NMOD	-1
17	co-culture	co-culture	I-NP	NN	O	19	NMOD	-1
18	assay	assay	I-NP	NN	O	19	NMOD	-1
19	system	system	I-NP	NN	O	15	PMOD	0
20	.	.	O	.	O	6	P	-1

1	These	These	B-NP	DT	O	2	NMOD	-1
2	studies	study	I-NP	NNS	O	3	SUB	-1
3	indicate	indicate	B-VP	VBP	O	0	ROOT	-1
4	that	that	B-SBAR	IN	O	3	VMOD	-1
5	Shh	Shh	B-NP	NN	O	6	NMOD	-1
6	peptide	peptide	I-NP	NN	O	11	SUB	-1
7	produced	produce	B-VP	VBN	O	6	NMOD	9	produced
8	by	by	B-PP	IN	O	7	VMOD	-1
9	melanoma	melanoma	B-NP	NN	B-cell_type	10	NMOD	-1
10	cells	cell	I-NP	NNS	I-cell_type	8	PMOD	-1
11	induces	induce	B-VP	VBZ	O	4	SBAR	17	induces
12	Patched	Patch	I-VP	VBN	O	13	NMOD	-1
13	expression	expression	B-NP	NN	O	11	OBJ	9	expression
14	in	in	B-PP	IN	O	11	VMOD	-1
15	fibroblasts	fibroblast	B-NP	NNS	B-cell_type	14	PMOD	-1
16	.	.	O	.	O	3	P	-1

1	To	To	B-VP	TO	O	2	VMOD	-1
2	study	study	I-VP	VB	O	10	VMOD	-1
3	tumor	tumor	B-NP	NN	O	5	NMOD	-1
4	related	related	I-NP	JJ	O	3	AMOD	-1
5	angiogenesis	angiogenesis	I-NP	NN	O	9	NMOD	3	angiogenesis
6	a	a	B-NP	DT	O	9	NMOD	-1
7	vascular	vascular	I-NP	JJ	O	9	NMOD	-1
8	window	window	I-NP	NN	O	9	NMOD	-1
9	model	model	I-NP	NN	O	2	OBJ	-1
10	was	be	B-VP	VBD	O	0	ROOT	-1
11	used	use	I-VP	VBN	O	10	VC	0
12	to	to	B-VP	TO	O	13	VMOD	-1
13	monitor	monitor	I-VP	VB	O	11	VMOD	-1
14	tumor	tumor	B-NP	NN	O	15	NMOD	-1
15	vascularity	vascularity	I-NP	NN	O	13	OBJ	-1
16	.	.	O	.	O	10	P	-1

1	Treatment	Treatment	B-NP	NN	O	5	SUB	19	Treatment
2	with	with	B-PP	IN	O	1	NMOD	-1
3	cyclopamine	cyclopamine	B-NP	NN	O	2	PMOD	-1
4	significantly	significantly	B-ADVP	RB	O	5	VMOD	-1
5	attenuated	attenuate	B-VP	VBD	O	0	ROOT	18	attenuated
6	vascular	vascular	B-NP	JJ	O	7	NMOD	-1
7	formation	formation	I-NP	NN	O	5	OBJ	2	formation
8	by	by	B-PP	IN	O	5	VMOD	-1
9	a	a	B-NP	DT	O	10	NMOD	-1
10	factor	factor	I-NP	NN	O	8	PMOD	-1
11	of	of	B-PP	IN	O	10	NMOD	-1
12	2.5	2.5	B-NP	CD	O	18	NMOD	-1
13	(	(	O	(	O	18	DEP	-1
14	P	P	B-NP	NN	O	18	DEP	-1
15	less	less	B-ADJP	JJR	O	14	NMOD	-1
16	than	than	B-PP	IN	O	15	AMOD	-1
17	0.001	0.001	B-NP	CD	O	16	PMOD	-1
18	)	)	O	)	O	11	PMOD	-1
19	and	and	O	CC	O	5	VMOD	-1
20	altered	alter	B-VP	VBN	O	5	VMOD	16	altered
21	vascular	vascular	B-NP	JJ	O	22	NMOD	-1
22	morphology	morphology	I-NP	NN	O	20	OBJ	-1
23	.	.	O	.	O	5	P	-1

1	Furthermore	Furthermore	B-ADVP	RB	O	4	VMOD	-1
2	,	,	O	,	O	4	P	-1
3	cyclopamine	cyclopamine	B-NP	NN	O	4	SUB	-1
4	reduced	reduce	B-VP	VBD	O	0	ROOT	0
5	tumor	tumor	B-NP	NN	O	8	NMOD	-1
6	blood	blood	I-NP	NN	O	8	NMOD	-1
7	vessel	vessel	I-NP	NN	O	8	NMOD	-1
8	permeability	permeability	I-NP	NN	O	4	OBJ	-1
9	to	to	B-PP	TO	O	4	VMOD	-1
10	FITC	FITC	B-NP	NN	O	12	NMOD	-1
11	labeled	labeled	I-NP	JJ	O	12	NMOD	19	labeled
12	dextran	dextran	I-NP	NN	O	9	PMOD	-1
13	while	while	B-SBAR	IN	O	4	VMOD	-1
14	having	have	B-VP	VBG	O	13	SBAR	-1
15	no	no	B-NP	DT	O	16	NMOD	-1
16	effect	effect	I-NP	NN	O	14	OBJ	16	effect
17	on	on	B-PP	IN	O	14	VMOD	-1
18	normal	normal	B-NP	JJ	O	20	NMOD	-1
19	blood	blood	I-NP	NN	O	20	NMOD	-1
20	vessels	vessel	I-NP	NNS	O	17	PMOD	-1
21	.	.	O	.	O	4	P	-1

1	These	These	B-NP	DT	O	2	NMOD	-1
2	studies	study	I-NP	NNS	O	3	SUB	-1
3	suggest	suggest	B-VP	VBP	O	0	ROOT	-1
4	that	that	B-SBAR	IN	O	3	VMOD	-1
5	Hedgehog	Hedgehog	B-NP	NN	O	6	NMOD	-1
6	signaling	signaling	I-NP	NN	O	7	SUB	0
7	regulates	regulate	B-VP	VBZ	O	4	SBAR	16	regulates
8	melanoma	melanoma	B-NP	NN	O	11	NMOD	-1
9	related	related	I-NP	JJ	O	11	NMOD	-1
10	vascular	vascular	I-NP	JJ	O	11	NMOD	-1
11	formation	formation	I-NP	NN	O	13	NMOD	2	formation
12	and	and	I-NP	CC	O	13	NMOD	-1
13	function	function	I-NP	NN	O	7	OBJ	-1
14	.	.	O	.	O	3	P	-1

